ACE Report Cover
Intravenous metamizole has a greater analgesic efficacy than paracetamol following THA
Language
Download
Cite
+ Favorites
Language
Download
Cite
+ Favorites
AceReport Image
ARTHROPLASTY
Intravenous metamizole has a greater analgesic efficacy than paracetamol following THA .

Treatment of postoperative pain after total hip arthroplasty: comparison between metamizol and paracetamol as adjunctive to opioid analgesics-prospective, double-blind, randomised study

Arch Orthop Trauma Surg. 2014 May;134(5):631-6. doi: 10.1007/s00402-014-1979-7. Epub 2014 Mar 28.

94 patients scheduled to undergo total hip arthroplasty were randomized to receive patient-controlled morphine paired with either intravenous metamizole or paracetamol as the postoperative analgesic regimen. The purpose of this study was to compare these two pharmacological interventions with respect to analgesic efficacy over the first 24 postoperative hours. Results indicated that patients in the metamizole group experienced significantly less pain and consumed significantly less morphine when compared to those in the paracetamol group. Patient sex, body weight and intraoperative blood loss were not significantly associated with postoperative pain in either study group. There was a significant negative correlation between patient age and postoperative pain in the paracetamol group only.

Unlock the Full ACE Report

You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now

Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics

Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics

Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions

Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics

Or upgrade today and gain access to all OrthoEvidence
content for as little as $1.99 per week.
0 of 4 monthly FREE articles unlocked
You've reached your limit of 4 free articles views this month

Access to OrthoEvidence for as little as $1.99 per week.

Stay connected with latest evidence. Cancel at any time.
  • Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
  • Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
  • Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Upgrade
Welcome Back!
Forgot Password?
Start your FREE trial today!

Account will be affiliated with


OR
Forgot Password?

OR
Please check your email

If an account exists with the provided email address, a password reset email will be sent to you. If you don't see an email, please check your spam or junk folder.

For further assistance, contact our support team.

Translate ACE Report

OrthoEvidence utilizes a third-party translation service to make content accessible in multiple languages. Please note that while every effort is made to ensure accuracy, translations may not always be perfect.

Cite this ACE Report

OrthoEvidence. Intravenous metamizole has a greater analgesic efficacy than paracetamol following THA. ACE Report. 2014;3(7):74. Available from: https://myorthoevidence.com/AceReport/Show/intravenous-metamizole-has-a-greater-analgesic-efficacy-than-paracetamol-following-tha

Copy Citation
Please login to enable this feature

To access this feature, you must be logged into an active OrthoEvidence account. Please log in or create a FREE trial account.

Premium Member Feature

To access this feature, you must be logged into a premium OrthoEvidence account.

Share this ACE Report